Get started
Aurobindo Pharma LtdAurobindo Pharma LtdAurobindo Pharma Ltd

Aurobindo Pharma Ltd

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFsBonds
Full chart
Full chart

Compare with Aurobindo Pharma Ltd



Key stats


Market capitalization
‪960.88 B‬ INR
Dividend yield (indicated)
0.24%
Price to earnings Ratio (TTM)
26.2
Basic EPS (TTM)
64.0 INR
Net income (FY)
‪35.05 B‬ INR
Revenue (FY)
‪334.07 B‬ INR
Shares float
‪275.94 M‬
Beta (1Y)
0.15

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
‪46.45 K‬
Change (1Y)
‪+5.71 K‬+14.00%
Revenue / Employee (1Y)
‪7.19 M‬ INR
Net income / Employee (1Y)
‪754.44 K‬ INR

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Kambam Nithyananda Reddy
Website
aurobindo.com
Headquarters
Hyderabad
Founded
1986
IPO date
Jan 19, 1995
ISIN
INE406A01037
FIGI
BBG000BMFTS8
Identifiers
ISIN INE406A01037
CFI code
ESVUFN
Aurobindo Pharma Ltd. engages in the manufacture of generic pharmaceutical and active pharmaceutical ingredients. It operates under the following geographical segments: India, USA, Europe, and Rest of the World. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral

Analyst rating


An aggregate view of professional's ratings.
Neutral
Neutral
Neutral

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


VWO
Vanguard FTSE Emerging Markets ETF
Weight0.04%
Market value‪70.81 M‬
IEMG
iShares Core MSCI Emerging Markets ETF
Weight0.03%
Market value‪50.78 M‬
INDA
iShares MSCI India ETF
Weight0.34%
Market value‪19.92 M‬
EIMU
iShares Core MSCI EM IMI UCITS ETF
Weight0.04%
Market value‪16.77 M‬
EIMI
iShares Core MSCI EM IMI UCITS ETF
Weight0.04%
Market value‪16.77 M‬
IIND
iShares MSCI India UCITS ETF
Weight0.35%
Market value‪16.64 M‬
AVEM
Avantis Emerging Markets Equity ETF
Weight0.05%
Market value‪14.45 M‬
SPEM
State Street SPDR Portfolio Emerging Markets ETF
Weight0.08%
Market value‪14.34 M‬
EEM
iShares MSCI Emerging Index Fund
Weight0.04%
Market value‪11.74 M‬
EMXC
iShares MSCI Emerging Markets ex China ETF
Weight0.04%
Market value‪11.73 M‬
PHARMABEES
Nippon India Nifty Pharma ETF Units Exchange Traded Fund
Weight4.69%
Market value‪8.67 M‬

Explore more ETFs 

Frequently asked questions


The current price of AUROPHARMA is 1,692.8 INR — it has increased by 0.76% in the past 24 hours. Watch Aurobindo Pharma Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Aurobindo Pharma Ltd stocks are traded under the ticker AUROPHARMA.
AUROPHARMA stock has fallen by −0.55% compared to the previous week, the month change is a 3.08% rise, over the last year Aurobindo Pharma Ltd has showed a 54.98% increase.
We've gathered analysts' opinions on Aurobindo Pharma Ltd future price: according to them, AUROPHARMA price has a max estimate of 1,980.00 INR and a min estimate of 1,270.00 INR. Watch AUROPHARMA chart and read a more detailed Aurobindo Pharma Ltd stock forecast: see what analysts think of Aurobindo Pharma Ltd and suggest that you do with its stocks.
AUROPHARMA reached its all-time high on Sep 24, 2026 with the price of 1,740.0 INR, and its all-time low was 4.6 INR and was reached on Jan 4, 1999. View more price dynamics on AUROPHARMA chart.
See other stocks reaching their highest and lowest prices.
AUROPHARMA stock is 1.42% volatile and has beta coefficient of 0.15. Track Aurobindo Pharma Ltd stock price on the chart and check out the list of the most volatile stocks — is Aurobindo Pharma Ltd there?
Today Aurobindo Pharma Ltd has the market capitalization of ‪960.88 B‬, it has increased by 0.18% over the last week.
Yes, you can track Aurobindo Pharma Ltd financials in yearly and quarterly reports right on TradingView.
Aurobindo Pharma Ltd is going to release the next earnings report on Nov 14, 2026. Keep track of upcoming events with our Earnings Calendar.
AUROPHARMA earnings for the last quarter are 17.86 INR per share, whereas the estimation was 17.26 INR resulting in a 3.46% surprise. The estimated earnings for the next quarter are 19.54 INR per share. See more details about Aurobindo Pharma Ltd earnings.
Aurobindo Pharma Ltd revenue for the last quarter amounts to ‪91.50 B‬ INR, despite the estimated figure of ‪90.05 B‬ INR. In the next quarter, revenue is expected to reach ‪99.39 B‬ INR.
AUROPHARMA net income for the last quarter is ‪10.33 B‬ INR, while the quarter before that showed ‪9.21 B‬ INR of net income which accounts for 0.00% change. Track more Aurobindo Pharma Ltd financial stats to get the full picture.
Yes, AUROPHARMA dividends are paid quarterly. The last dividend per share was 4.00 INR. As of today, Dividend Yield (TTM)% is 0.24%. Tracking Aurobindo Pharma Ltd dividends might help you take more informed decisions.
Aurobindo Pharma Ltd dividend yield was 0.31% in 2025, and payout ratio reached 6.63%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 6, 2026, the company has ‪46.45 K‬ employees. See our rating of the largest employees — is Aurobindo Pharma Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aurobindo Pharma Ltd EBITDA is ‪71.33 B‬ INR, and current EBITDA margin is 22.36%. See more stats in Aurobindo Pharma Ltd financial statements.
Like other stocks, AUROPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aurobindo Pharma Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aurobindo Pharma Ltd technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aurobindo Pharma Ltd stock shows the buy signal. See more of Aurobindo Pharma Ltd technicals for a more comprehensive analysis.